Investors & Media International Stem Cell Corporation Announces Publication of Preclinical Results Demonstrating Treatment of Parkinson's Disease in Cell Transplantation International Stem Cell Corporation Announces Operating Results for the Three-Months Ended March 31, 2016 International Stem Cell Corporation Announces 2015 Fourth Quarter and Year-End Results International Stem Cell Corporation to Raise $6.3 Million Through a Private Placement to Fund Phase I Clinical Trial International Stem Cell Corporation Announces Commencement of Enrollment of Phase I Trial of ISC-hpNSC International Stem Cell Corporation Signed a Clinical Service Agreement With the Florey Institute of Neuroscience and Mental Health International Stem Cell Corporation Receives Authorization to Initiate Phase I/IIa Clinical Trial of ISC-hpNSC for the Treatment of Parkinson's Disease International Stem Cell Corporation Announces Launch Plans for New Nano-Compound Products International Stem Cell Corporation Announces Operating Results for the Three- and Nine-Months Ended September 30, 2015 International Stem Cell Corporation Moves Forward With Parkinson's Disease Clinical Trials in Australia 2 3 4 5 6 7 8 9 10 11 12 << < > >>
